Digital microfluidics and biochip technologies represent a rapidly evolving interdisciplinary field that integrates principles of physics, chemistry and engineering to manipulate discrete droplets ...

(Nanowerk Spotlight) For decades, microfluidics has held promise as a revolutionary technology, yet widespread adoption outside research labs has remained elusive. Microfluidic devices enable precise ...

Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...

Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ink technology, are pleased to announce the ...

Digital SPR TM is a next-generation technology for characterizing biomolecular interactions. By combining digital microfluidics (DMF) with SPR, digital SPR systems can effectively bypass common ...

Amidst the crackle of cellular signaling, it can be hard to distinguish between cells that are quick on the draw, and those that take a long time “drawing a bead” before they finally fire. When the ...

Oak Brook, IL – The February 2023 issue of SLAS Technology contains a set of four original research articles and one review article covering digital microfluidics (DMF), cryopreservation, colorectal ...

CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...

UK-based biotech firm Nuclera has announced it has acquired Taiwan-based E Ink Holdings (EIH)'s digital microfluidics unit to form its US subsidiary. Combining the technologies of the two companies ...

CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...